The Village
Hartford, Connecticut, 06105, United States
NCT Number: NCT04064463
Phosphatidylethanol (PEth) is a direct biomarker of alcohol that can detect moderate to heavy drinking with high sensitivity and specificity over 3-week periods. Reinforcing negative PEth results alongside attendance may increase the proportion of participants who respond to CM during and post treatment. In the proposed study, the investigators will collect PEth samples every 3 weeks for 12 weeks in 150 participants initiating outpatient treatment for alcohol use disorders. Using a two-group randomized design, participants will be assigned to standard care with PEth monitoring alone or with CM for attending treatment and submitting PEth negative samples. Compared to standard care and monitoring, the investigators expect that the CM intervention will result in greater attendance, more PEth negative samples, and higher proportions of self-reported non-drinking days, along with lower proportions of heavy drinking days, over the short term and the long term, measured throughout a 12-month follow-up. The investigators anticipate that the reinforcement intervention may decrease other drug use and sexual risk behaviors that spread HIV, reduce psychiatric symptoms, and improve quality of life as well.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hartford, Connecticut, 06105, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
standard treatment for substance use disorders, along with sample monitoring
Participants can earn reinforcement for attending group and abstinence from alcohol
Time frame: 12 weeks
longest consecutive days attended groups
Time frame: 12 weeks
number of negative PEth samples
UConn Health
Other
Acronym: Peth
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02135237
Alcohol Use Disorder, Alcohol-Related Disorders
New Britain, Connecticut, United States
View Trial DetailsNCT02143037
Alcohol Use Disorder, Alcohol-Related Disorders
Bridgeport, Connecticut, United States
View Trial DetailsNCT06304467
Alcohol Liver Disease, Alcohol Use Disorder
Los Angeles, California, United States
View Trial DetailsNCT04523922
Alcohol Use Disorder, Alcohol-Related Disorders
Charleston, South Carolina, United States
View Trial Details